Saklayen MG. The global epidemic of the metabolic syndrome. Curr Hypertens Rep. 2018;20(2):12. https://doi.org/10.1007/s11906-018-0812-z.

Article  PubMed  PubMed Central  Google Scholar 

Kassi E, Pervanidou P, Kaltsas G, Chrousos G. Metabolic syndrome: definitions and controversies. BMC Med. 2011;9:48. https://doi.org/10.1186/1741-7015-9-48.

Article  PubMed  PubMed Central  Google Scholar 

Arhire LI, Mihalache L, Covasa M. Irisin: a hope in understanding and managing obesity and metabolic syndrome. Front Endocrinol (Lausanne). 2019;10:524. https://doi.org/10.3389/fendo.2019.00524.

Article  PubMed  PubMed Central  Google Scholar 

Boström P, Wu J, Jedrychowski MP, et al. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012;481(7382):463–8. https://doi.org/10.1038/nature10777.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee P, Linderman JD, Smith S, et al. Irisin and FGF21 are cold-induced endocrine activators of brown fat function in humans. Cell Metab. 2014;19(2):302–9. https://doi.org/10.1016/j.cmet.2013.12.017.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hofmann T, Elbelt U, Stengel A. Irisin as a muscle-derived hormone stimulating thermogenesis–a critical update. Peptides. 2014;54:89–100. https://doi.org/10.1016/j.peptides.2014.01.016.

Article  CAS  PubMed  Google Scholar 

Castillo-Quan JI. From white to brown fat through the PGC-1α-dependent myokine irisin: implications for diabetes and obesity. Dis Model Mech. 2012;5(3):293–5. https://doi.org/10.1242/dmm.009894.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Polyzos SA, Kountouras J, Shields K, Mantzoros CS. Irisin: a renaissance in metabolism? Metabolism. 2013;62(8):1037–44. https://doi.org/10.1016/j.metabol.2013.04.008.

Article  CAS  PubMed  Google Scholar 

Park KH, Zaichenko L, Brinkoetter M, et al. Circulating irisin in relation to insulin resistance and the metabolic syndrome [published correction appears in J Clin Endocrinol Metab. 2014 May;99(5):1910]. J Clin Endocrinol Metab. 2013;98(12):4899–907. https://doi.org/10.1210/jc.2013-2373.

Article  CAS  PubMed  Google Scholar 

Huh JY, Panagiotou G, Mougios V, et al. FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism. 2012;61(12):1725–38. https://doi.org/10.1016/j.metabol.2012.09.002.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Crujeiras AB, Pardo M, Arturo RR, et al. Longitudinal variation of circulating irisin after an energy restriction-induced weight loss and following weight regain in obese men and women. Am J Hum Biol. 2014;26(2):198–207. https://doi.org/10.1002/ajhb.22493.

Article  PubMed  Google Scholar 

Gutierrez-Repiso C, Garcia-Serrano S, Rodriguez-Pacheco F, et al. FNDC5 could be regulated by leptin in adipose tissue. Eur J Clin Invest. 2014;44(10):918–25. https://doi.org/10.1111/eci.12324.

Article  CAS  PubMed  Google Scholar 

Löffler D, Müller U, Scheuermann K, et al. Serum irisin levels are regulated by acute strenuous exercise. J Clin Endocrinol Metab. 2015;100(4):1289–99. https://doi.org/10.1210/jc.2014-2932.

Article  CAS  PubMed  Google Scholar 

Stengel A, Hofmann T, Goebel-Stengel M, Elbelt U, Kobelt P, Klapp BF. Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity–correlation with body mass index. Peptides. 2013;39:125–30. https://doi.org/10.1016/j.peptides.2012.11.014.

Article  CAS  PubMed  Google Scholar 

Crujeiras AB, Zulet MA, Lopez-Legarrea P, et al. Association between circulating irisin levels and the promotion of insulin resistance during the weight maintenance period after a dietary weight-lowering program in obese patients. Metabolism. 2014;63(4):520–31. https://doi.org/10.1016/j.metabol.2013.12.007.

Article  CAS  PubMed  Google Scholar 

Pekkala S, Wiklund PK, Hulmi JJ, et al. Are skeletal muscle FNDC5 gene expression and irisin release regulated by exercise and related to health? J Physiol. 2013;591(21):5393–400. https://doi.org/10.1113/jphysiol.2013.263707.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Moreno-Navarrete JM, Ortega F, Serrano M, et al. Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. J Clin Endocrinol Metab. 2013;98(4):E769–78. https://doi.org/10.1210/jc.2012-2749.

Article  CAS  PubMed  Google Scholar 

Choi YK, Kim MK, Bae KH, et al. Serum irisin levels in new-onset type 2 diabetes. Diabetes Res Clin Pract. 2013;100(1):96–101. https://doi.org/10.1016/j.diabres.2013.01.007.

Article  CAS  PubMed  Google Scholar 

Liu JJ, Wong MD, Toy WC, et al. Lower circulating irisin is associated with type 2 diabetes mellitus. J Diabetes Complicat. 2013;27(4):365–9. https://doi.org/10.1016/j.jdiacomp.2013.03.002.

Article  Google Scholar 

Duran ID, Gülçelik NE, Ünal M, et al. Irisin levels in the progression of diabetes in sedentary women. Clin Biochem. 2015;48(18):1268–72. https://doi.org/10.1016/j.clinbiochem.2015.07.098.

Article  CAS  PubMed  Google Scholar 

Huerta AE, Prieto-Hontoria PL, Fernández-Galilea M, et al. Circulating irisin and glucose metabolism in overweight/obese women: effects of α-lipoic acid and eicosapentaenoic acid. J Physiol Biochem. 2015;71(3):547–58. https://doi.org/10.1007/s13105-015-0400-5.

Article  CAS  PubMed  Google Scholar 

Yang M, Chen P, Jin H, et al. Circulating levels of irisin in middle-aged first-degree relatives of type 2 diabetes mellitus - correlation with pancreatic β-cell function. Diabetol Metab Syndr. 2014;6(1):133. https://doi.org/10.1186/1758-5996-6-133.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Qiu S, Cai X, Yin H, et al. Association between circulating irisin and insulin resistance in non-diabetic adults: a meta-analysis. Metabolism. 2016;65(6):825–34. https://doi.org/10.1016/j.metabol.2016.02.006.

Article  CAS  PubMed  Google Scholar 

Sesti G, Andreozzi F, Fiorentino TV, et al. High circulating irisin levels are associated with insulin resistance and vascular atherosclerosis in a cohort of nondiabetic adult subjects. Acta Diabetol. 2014;51(5):705–13. https://doi.org/10.1007/s00592-014-0576-0.

Article  CAS  PubMed  Google Scholar 

Gao S, Li F, Li H, Huang Y, Liu Y, Chen Y. Effects and molecular mechanism of GST-irisin on lipolysis and autocrine function in 3T3-L1 adipocytes. PLoS ONE. 2016;11(1):e0147480. https://doi.org/10.1371/journal.pone.0147480.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xiong XQ, Chen D, Sun HJ, et al. FNDC5 overexpression and irisin ameliorate glucose/lipid metabolic derangements and enhance lipolysis in obesity. Biochim Biophys Acta. 2015;1852(9):1867–75. https://doi.org/10.1016/j.bbadis.2015.06.017.

Article  CAS  PubMed  Google Scholar 

Huh JY, Dincer F, Mesfum E, Mantzoros CS. Irisin stimulates muscle growth-related genes and regulates adipocyte differentiation and metabolism in humans. Int J Obes (Lond). 2014;38(12):1538–44. https://doi.org/10.1038/ijo.2014.42.

Article  CAS  Google Scholar 

Moreno M, Moreno-Navarrete JM, Serrano M, et al. Circulating irisin levels are positively associated with metabolic risk factors in sedentary subjects. PLoS ONE. 2015;10(4):e0124100. https://doi.org/10.1371/journal.pone.0124100.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tang S, Zhang R, Jiang F, et al. Circulating irisin levels are associated with lipid and uric acid metabolism in a Chinese population. Clin Exp Pharmacol Physiol. 2015;42(9):896–901. https://doi.org/10.1111/1440-1681.12439.

Article  CAS  PubMed  Google Scholar 

Jang HB, Kim HJ, Kang JH, Park SI, Park KH, Lee HJ. Association of circulating irisin levels with metabolic and metabolite profiles of Korean adolescents. Metabolism. 2017;73:100–8. https://doi.org/10.1016/j.metabol.2017.05.007.

Article  CAS  PubMed  Google Scholar 

Panagiotou G, Mu L, Na B, Mukamal KJ, Mantzoros CS. Circulating irisin, omentin-1, and lipoprotein subparticles in adults at higher cardiovascular risk. Metabolism. 2014;63(10):1265–71. https://doi.org/10.1016/j.metabol.2014.06.001.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Oelmann S, Nauck M, Völzke H, Bahls M, Friedrich N. Circulating irisin concentrations are associated with a favourable lipid profile in the general population. PLoS ONE. 2016;11(4):e0154319. https://doi.org/10.1371/journal.pone.0154319.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Anastasilakis AD, Polyzos SA, Saridakis ZG, et al. Circulating irisin in healthy, young individuals: day-night rhythm, effects of food intake and exercise, and associations with gender, physical activity, diet, and body composition. J Clin Endocrinol Metab. 2014;99(9):3247–55. https://doi.org/10.1210/jc.2014-1367.

Article  CAS  PubMed  Google Scholar 

Mehrabian S, Taheri E, Karkhaneh M, Qorbani M, Hosseini S. Association of circulating irisin levels with normal weight obesity, glycemic and lipid profile. J Diabetes Metab Disord. 2016;15:17.